Skip to main content

#151704

Anti-CLEC9A [397]

Cat. #151704

Anti-CLEC9A [397]

Cat. #: 151704

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Mouse DNGR1

Class: Monoclonal

Application: WB

Reactivity: Mouse

Host: Rat

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CLEC9A [397]
  • Alternate name: C-Type Lectin Domain Family 9 Member A; HEEE9341; UNQ9341; DNGR-1; CD37; DNGR1
  • Research fields: Immunology;Stem cell biology
  • Clone: 397
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Mouse
  • Host: Rat
  • Application: WB
  • Description: Recognises mouse DNGR-1, also known as CLEC9A, which is a highly specific marker of the CD8a+ and the CD103+ DC subsets, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.
  • Immunogen: RBL-2H3 cells expressing mouse DNGR-1 fused to an HA epitope
  • Isotype: IgG2a
  • Myeloma used: Y3.AG.1.2.3
  • Recommended controls: rat IgG2a isotype-matched control mAbs

Target Details

  • Target: Mouse DNGR1
  • Tissue cell line specificity: rat IgG2a isotype-matched control mAbs
  • Target background: Recognises mouse DNGR-1, also known as CLEC9A, which is a highly specific marker of the CD8a+ and the CD103+ DC subsets, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Joffre et al. 2010. Eur J Immunol. 40(5):1255-65. PMID: 20333625.
  • Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.
  • Sancho et al. 2009. Nature. 458(7240):899-903. PMID: 19219027.
  • Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.
  • Sancho et al. 2008. J Clin Invest. 118(6):2098-110. PMID: 18497879.
  • Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.